Gastric Cancer Clinical Trials in Nanjing, Jiangsu
15 recruitingNanjing, Jiangsu, China
Showing 1–15 of 15 trials
Recruiting
Phase 2
Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma
Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University48 enrolled1 locationNCT07277439
Recruiting
Phase 2
Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
Gastric CancerEsophagogastric Junction Adenocarcinoma
Zekuan Xu30 enrolled1 locationNCT06461910
Recruiting
Phase 1
Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer
Advanced Gastric Cancer
Jia Wei18 enrolled1 locationNCT07298200
Recruiting
AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CT
Gastric Cancer StageGastric Cancer Patients Undergoing Gastrectomy
The First Affiliated Hospital with Nanjing Medical University8,000 enrolled1 locationNCT07250347
Recruiting
Phase 1
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Liver CancerGastric CancerSolid Tumor
Qurgen Inc.96 enrolled11 locationsNCT06873659
Recruiting
Phase 2
Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy
Gastric Cancers
The First Affiliated Hospital with Nanjing Medical University40 enrolled1 locationNCT06895447
Recruiting
Not Applicable
Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy
Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University30 enrolled1 locationNCT07056010
Recruiting
Phase 2
Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer
Gastric Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School45 enrolled1 locationNCT06791148
Recruiting
The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer
Gastric CarcinomaGastric (Cardia, Body) CancerGastric Neoplasm+1 more
Lin Liu112 enrolled1 locationNCT06702683
Recruiting
Phase 2
A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer
Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University40 enrolled1 locationNCT06555471
Recruiting
Phase 2
Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
Gastric CancerGastric Cancer Metastatic to Regional Lymph Nodes
The First Affiliated Hospital with Nanjing Medical University40 enrolled1 locationNCT06341595
Recruiting
Not Applicable
ONS in Gastric Cancer After Total Gastrectomy
Gastric Cancer
Jinling Hospital, China60 enrolled1 locationNCT05823272
Recruiting
Phase 2
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
Gastric CancerGastroesophageal-junction CancerCarcinoma+4 more
The First Affiliated Hospital with Nanjing Medical University80 enrolled1 locationNCT05494060
Recruiting
Phase 2
Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma
Gastric CancerGastroesophageal-junction Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School140 enrolled3 locationsNCT05687357
Recruiting
Not Applicable
Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer
Stage III Gastric Cancer
Jinling Hospital, China696 enrolled1 locationNCT05253716